914 related articles for article (PubMed ID: 10097135)
1. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.
Rao VV; Dahlheimer JL; Bardgett ME; Snyder AZ; Finch RA; Sartorelli AC; Piwnica-Worms D
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3900-5. PubMed ID: 10097135
[TBL] [Abstract][Full Text] [Related]
2. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
3. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
[TBL] [Abstract][Full Text] [Related]
4. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
5. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier.
Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D
Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495
[TBL] [Abstract][Full Text] [Related]
6. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus.
Ghersi-Egea JF; Strazielle N
Microsc Res Tech; 2001 Jan; 52(1):83-8. PubMed ID: 11135451
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system pharmacokinetics of the Mdr1 P-glycoprotein substrate CP-615,003: intersite differences and implications for human receptor occupancy projections from cerebrospinal fluid exposures.
Venkatakrishnan K; Tseng E; Nelson FR; Rollema H; French JL; Kaplan IV; Horner WE; Gibbs MA
Drug Metab Dispos; 2007 Aug; 35(8):1341-9. PubMed ID: 17470526
[TBL] [Abstract][Full Text] [Related]
8. Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain.
Sugiyama Y; Kusuhara H; Suzuki H
J Control Release; 1999 Nov; 62(1-2):179-86. PubMed ID: 10518649
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance caused by multidrug resistance-associated proteins.
Wijnholds J
Novartis Found Symp; 2002; 243():69-79; discussion 80-2, 180-5. PubMed ID: 11990783
[TBL] [Abstract][Full Text] [Related]
10. Monitoring interactions at ATP-dependent drug efflux pumps.
Hendrikse NH
Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
[TBL] [Abstract][Full Text] [Related]
11. Visualization of multidrug resistance in vivo.
Hendrikse NH; Franssen EJ; van der Graaf WT; Vaalburg W; de Vries EG
Eur J Nucl Med; 1999 Mar; 26(3):283-93. PubMed ID: 10079321
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
Reichel V; Burghard S; John I; Huber O
Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
[TBL] [Abstract][Full Text] [Related]
13. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
14. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
Marroni M; Marchi N; Cucullo L; Abbott NJ; Signorelli K; Janigro D
Curr Drug Targets; 2003 May; 4(4):297-304. PubMed ID: 12699350
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
16. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
[TBL] [Abstract][Full Text] [Related]
17. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.
Wijnholds J; deLange EC; Scheffer GL; van den Berg DJ; Mol CA; van der Valk M; Schinkel AH; Scheper RJ; Breimer DD; Borst P
J Clin Invest; 2000 Feb; 105(3):279-85. PubMed ID: 10675353
[TBL] [Abstract][Full Text] [Related]
19. The blood-cerebrospinal fluid barrier: structure and functional significance.
Johanson CE; Stopa EG; McMillan PN
Methods Mol Biol; 2011; 686():101-31. PubMed ID: 21082368
[TBL] [Abstract][Full Text] [Related]
20. A balanced view of choroid plexus structure and function: Focus on adult humans.
Spector R; Keep RF; Robert Snodgrass S; Smith QR; Johanson CE
Exp Neurol; 2015 May; 267():78-86. PubMed ID: 25747036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
